[go: up one dir, main page]

NO20003511L - Lipase-inhiberende polymerer - Google Patents

Lipase-inhiberende polymerer

Info

Publication number
NO20003511L
NO20003511L NO20003511A NO20003511A NO20003511L NO 20003511 L NO20003511 L NO 20003511L NO 20003511 A NO20003511 A NO 20003511A NO 20003511 A NO20003511 A NO 20003511A NO 20003511 L NO20003511 L NO 20003511L
Authority
NO
Norway
Prior art keywords
inhibiting polymers
lipase inhibiting
polymers
patient
methods
Prior art date
Application number
NO20003511A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003511D0 (no
Inventor
Iii Harry W Mandeville
Molly Kate Boie
Venkata R Garigapati
Original Assignee
Geltex Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharma Inc filed Critical Geltex Pharma Inc
Publication of NO20003511D0 publication Critical patent/NO20003511D0/no
Publication of NO20003511L publication Critical patent/NO20003511L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
NO20003511A 1998-01-09 2000-07-07 Lipase-inhiberende polymerer NO20003511L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US537998A 1998-01-09 1998-01-09
US09/166,510 US6267952B1 (en) 1998-01-09 1998-10-05 Lipase inhibiting polymers
PCT/US1999/000195 WO1999034786A2 (fr) 1998-01-09 1999-01-06 Polymeres inhibiteurs de lipase

Publications (2)

Publication Number Publication Date
NO20003511D0 NO20003511D0 (no) 2000-07-07
NO20003511L true NO20003511L (no) 2000-09-07

Family

ID=26674279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003511A NO20003511L (no) 1998-01-09 2000-07-07 Lipase-inhiberende polymerer

Country Status (20)

Country Link
US (6) US6267952B1 (fr)
EP (1) EP1043982B1 (fr)
JP (1) JP2002500182A (fr)
KR (1) KR100620634B1 (fr)
CN (2) CN1287489A (fr)
AT (1) ATE308979T1 (fr)
AU (1) AU747016B2 (fr)
BR (1) BR9907233A (fr)
CA (1) CA2318416A1 (fr)
DE (1) DE69928219T2 (fr)
DK (1) DK1043982T3 (fr)
ES (1) ES2253872T3 (fr)
HK (1) HK1079706A1 (fr)
HU (1) HUP0101128A3 (fr)
IL (1) IL137098A (fr)
NO (1) NO20003511L (fr)
NZ (1) NZ505296A (fr)
PL (1) PL193453B1 (fr)
RU (1) RU2207861C2 (fr)
WO (1) WO1999034786A2 (fr)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
PE20010588A1 (es) * 1999-09-10 2001-06-23 Procter & Gamble Conjugados polimericos inhibidores de enzimas proteoliticas y lipoliticas
ATE476998T1 (de) * 1999-09-10 2010-08-15 Procter & Gamble Polyoxyalkylen-konjugate als enzyminhibitoren
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
AR025587A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
EP1132389A1 (fr) 2000-03-06 2001-09-12 Vernalis Research Limited Nouveaux dérivés de l'azaindole pour le traitement de l'obésité
MXPA02012583A (es) * 2000-06-27 2003-04-10 Hoffmann La Roche Metodo para preparacion de una composicion.
DE60110232T2 (de) 2000-07-28 2006-01-19 F. Hoffmann-La Roche Ag Neue verwendung von lipase-inhibitoren
HRP20030029B1 (en) 2000-07-28 2005-06-30 F. Hoffmann - La Roche Ag New pharmaceutical composition
PT1311260E (pt) 2000-08-09 2008-05-02 Hoffmann La Roche Utilização de inibidores de lipase para o tratamento da dispepsia
US6900226B2 (en) 2000-09-06 2005-05-31 Hoffman-La Roche Inc. Neuropeptide Y antagonists
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) * 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6638926B2 (en) 2000-09-15 2003-10-28 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
AU2002221670B2 (en) 2000-10-16 2006-11-02 F. Hoffmann-La Roche Ag Indoline derivatives and their use as 5-HT2 receptor ligands
GB0030710D0 (en) 2000-12-15 2001-01-31 Hoffmann La Roche Piperazine derivatives
CA2432799C (fr) * 2000-12-21 2008-08-19 Vertex Pharmaceuticals Incorporated Composes de pyrazole presentant une grande utilite comme inhibiteurs de proteine kinase
CA2432085C (fr) 2000-12-27 2009-02-24 F. Hoffmann-La Roche Ag Derives d'indole et leur utilisation en tant que ligands de recepteurs 5-ht2b et 5-ht2c
GB0106177D0 (en) 2001-03-13 2001-05-02 Hoffmann La Roche Piperazine derivatives
DE60225274T2 (de) 2001-05-21 2009-03-26 F. Hoffmann-La Roche Ag Chinolinderivate als liganden für den neuropeptid-y-rezeptor
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US6787558B2 (en) 2001-09-28 2004-09-07 Hoffmann-La Roche Inc. Quinoline derivatives
GB0202015D0 (en) 2002-01-29 2002-03-13 Hoffmann La Roche Piperazine Derivatives
ES2304498T3 (es) 2002-02-04 2008-10-16 F. Hoffmann-La Roche Ag Derivados de quinolina como antagonistas de npy.
MXPA04007697A (es) * 2002-02-06 2004-11-10 Vertex Pharma Compuestos de heteroarilo utiles como inhibidores de gsk-3.
ATE512979T1 (de) * 2002-02-19 2011-07-15 Procter & Gamble Neue lipase aus pilzen
DE60316411T2 (de) 2002-02-28 2008-06-12 F. Hoffmann-La Roche Ag Thiazolderivate als npy-rezeptorantagonisten
ATE468336T1 (de) * 2002-03-15 2010-06-15 Vertex Pharma Azolylaminoazine als proteinkinasehemmer
AU2003223930A1 (en) * 2002-06-14 2003-12-31 Novo Nordisk A/S Pharmaceutical use of boronic acids and esters thereof
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
WO2004005265A1 (fr) 2002-07-05 2004-01-15 F. Hoffmann-La Roche Ag Derives de quinazoline
PT1532145E (pt) * 2002-08-02 2007-01-31 Vertex Pharma Composiçoes de pirazole úteis como inibidores de gsk-3
BR0313278A (pt) 2002-08-07 2005-07-05 Hoffmann La Roche Compostos, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo e sua utilização, método para o tratamento e profilaxia de enfermidades e obesidade e utilização dos compostos
EP1578816A1 (fr) * 2002-11-19 2005-09-28 Genzyme Corporation Derives polymeres d'acide boronique tenant lieu d'inhibiteurs de la lipase
US7601718B2 (en) * 2003-02-06 2009-10-13 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
GB0314967D0 (en) 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
CN100422179C (zh) 2003-08-12 2008-10-01 霍夫曼-拉罗奇有限公司 2-氨基-5-苯甲酰基噻唑npy拮抗剂
CA2533464A1 (fr) 2003-08-12 2005-02-17 F. Hoffmann-La Roche Ag Derives de thiazole utiles comme antagonistes de npy *
US20050239859A2 (en) * 2003-09-03 2005-10-27 Solvay Pharmaceuticals Gmbh Novel medical uses of 4,5-dihydro-1h-pyrazole derivatives having cb1- antagonistic activity
US20050143441A1 (en) * 2003-10-27 2005-06-30 Jochen Antel Novel medical combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
US20050124660A1 (en) * 2003-10-27 2005-06-09 Jochen Antel Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds
US7517890B2 (en) 2003-11-20 2009-04-14 Children's Hospital Medical Center GTPase inhibitors and methods of use
CA2548172A1 (fr) * 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines utiles comme inhibiteurs des proteines kinases
US20050244367A1 (en) * 2004-05-03 2005-11-03 Ilypsa, Inc. Phospholipase inhibitors localized in the gastrointestinal lumen
US7462394B2 (en) * 2004-05-06 2008-12-09 Ppg Industries Ohio, Inc. Method of stabilizing metal pigments against gassing
WO2006010268A1 (fr) * 2004-07-30 2006-02-02 Basf Ag Derives d'acide boronique polymeriques et utilisation dans la fabrication du papier
RU2007119315A (ru) * 2004-10-25 2008-11-27 Зольвай Фармасьютиклз Гмбх (De) Фармацевтические композиции, содержащие антагонисты каннабиноидного рецептора св1 и открыватели калиевых каналов, предназначенные для лечения сахарного диабета типа i, ожирения и связанных с ними состояний
CN101171252B (zh) 2005-05-03 2011-06-01 霍夫曼-拉罗奇有限公司 作为5-ht2配体的四环氮杂吡嗪并二氢吲哚类化合物
US7826982B2 (en) 2005-07-29 2010-11-02 Children's Hospital Medical Center Method of identifying inhibitors using a 3-D structure of RAC-1 GTPASE
EP1945635B1 (fr) 2005-08-18 2009-05-06 F.Hoffmann-La Roche Ag Derives de thiazolyle piperidine utile comme modulateurs du recepteur h3
JP2009504771A (ja) * 2005-08-18 2009-02-05 バーテックス ファーマシューティカルズ インコーポレイテッド ピラジンキナーゼ阻害剤
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
WO2007056163A2 (fr) * 2005-11-03 2007-05-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines utiles en tant qu'inhibiteurs de kinases
KR101047204B1 (ko) 2005-11-30 2011-07-06 에프. 호프만-라 로슈 아게 Ｈ3 조절제로서 사용하기 위한1,1-다이옥소-싸이오모폴린일 인돌일 메탄온 유도체
CN101316840B (zh) 2005-11-30 2012-08-08 霍夫曼-拉罗奇有限公司 1,5-取代的吲哚-2-基酰胺衍生物
ES2342979T3 (es) 2005-11-30 2010-07-20 F. Hoffmann-La Roche Ag Derivados de indol-2-carboxamida sustituidos en 5.
DE602006010433D1 (de) 2005-12-09 2009-12-24 Hoffmann La Roche Für die behandlung von obesitas geeignete tricyclische amidderivate
CN101326187A (zh) 2005-12-15 2008-12-17 霍夫曼-拉罗奇有限公司 吡咯并[2,3-c]吡啶衍生物
US7351708B2 (en) 2005-12-16 2008-04-01 Hoffmann-La Roche Inc. Pyrrolo [2,3-b] pyridine derivatives
US7432255B2 (en) 2006-05-16 2008-10-07 Hoffmann-La Roche Inc. 1H-indol-5-yl-piperazin-1-yl-methanone derivatives
BRPI0711740A2 (pt) 2006-05-30 2011-12-06 Hoffmann La Roche compostos, processo para a sua manufatura,composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3, método para o tratamento ou prevenção de obesidade, de diabetes do tipo ii, e uso dos compostos na manufatura de medicamentos
US7514433B2 (en) 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
DE602007004750D1 (de) * 2006-11-02 2010-03-25 Vertex Pharma Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine
US20080146559A1 (en) 2006-12-08 2008-06-19 Li Chen 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
WO2008077086A1 (fr) * 2006-12-19 2008-06-26 Vertex Pharmaceuticals Incorporated Aminopyridines utiles comme inhibiteurs de protéine kinases
EP2134709A1 (fr) 2007-03-09 2009-12-23 Vertex Pharmaceuticals, Inc. Utilisation des aminopyridines comme inhibiteurs de protéines kinases
MX2009009590A (es) * 2007-03-09 2009-11-10 Vertex Pharma Aminopirimidinas utiles como inhibidores de proteinas cinasas.
NZ579485A (en) * 2007-03-09 2012-02-24 Vertex Pharma Aminopyrimidines useful as inhibitors of protein kinases
NZ580343A (en) 2007-04-13 2012-03-30 Vertex Pharma Aminopyrimidines useful as kinase inhibitors
JP5389785B2 (ja) * 2007-05-02 2014-01-15 バーテックス ファーマシューティカルズ インコーポレイテッド キナーゼ阻害剤として有用なチアゾールおよびピラゾール
CA2688584A1 (fr) * 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines servant d'inhibiteurs de kinases
CA2694381A1 (fr) * 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines servant d'inhibiteurs de kinases
AU2008257044A1 (en) * 2007-05-24 2008-12-04 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
EP2183237A1 (fr) 2007-07-25 2010-05-12 F. Hoffmann-Roche AG Dérivés d'amide d'acide benzofurane- et benzo[b]thiophène-2-carboxylique et leur utilisation comme modulateurs du récepteur h3 de l'histamine
AU2008282156B2 (en) * 2007-07-31 2014-07-17 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1H-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
US8185398B2 (en) * 2007-12-31 2012-05-22 Intel-Ge Care Innovations Llc Reading device with shortcut read function
CN102215816A (zh) * 2008-09-03 2011-10-12 沃泰克斯药物股份有限公司 共晶和包含所述共晶的药物制剂
AU2011228758A1 (en) * 2010-03-13 2012-11-08 Eastpond Laboratories Limited Fat-binding compositions
CN102199172A (zh) * 2010-03-24 2011-09-28 金凯美(大连)医药科技有限公司 一种1-取代亚磷酰二氯的制备方法
WO2013166043A1 (fr) 2012-05-02 2013-11-07 Children's Hospital Medical Center Rajeunissement de cellules précurseurs
US10028503B2 (en) 2014-06-18 2018-07-24 Children's Hospital Medical Center Platelet storage methods and compositions for same
US20220288197A1 (en) 2019-08-16 2022-09-15 Children’s Hospital Medicai Center Methods of treating a subject with a cdc42-specific inhibitor

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7017227A (fr) 1969-12-27 1971-06-29
US4211765A (en) * 1971-10-12 1980-07-08 Monsanto Company Method for controlling obesity
US3923972A (en) 1971-10-12 1975-12-02 Monsanto Co Method of lowering blood cholesterol level
IT1052819B (it) 1975-12-12 1981-07-20 Fargal Pharmasint Lab Biochim Preparato inibitore dell assorbimento dei lipidi a base di dietilamminoetildestrano
US4265879A (en) 1977-09-13 1981-05-05 Monsanto Company Method for controlling blood triglycerides
US4218443A (en) 1979-01-15 1980-08-19 Hoffmann-La Roche Inc. Polyether ionophores as antiobesity and hypotriglyceridemic agents
US4302450A (en) 1979-01-15 1981-11-24 Hoffmann-La Roche Inc. Polyether ionophores as antiobesity and hypotriglyceridemic agents
US4432968A (en) 1980-10-20 1984-02-21 The Dow Chemical Company Weight control with fat imbibing polymers
AU7653081A (en) 1980-10-20 1982-04-29 Dow Chemical Company, The T-butylstyrene copolymers for controlling body weight of animals
US5597810A (en) 1984-12-27 1997-01-28 Hoffman; Allan S. Method for reducing absorption of undesired lipids in the gastrointestinal tract
US5200183A (en) 1987-11-19 1993-04-06 Oklahoma Medical Research Foundation Recombinant bile salt activated lipases
US4959179A (en) 1989-01-30 1990-09-25 Lever Brothers Company Stabilized enzymes liquid detergent composition containing lipase and protease
US5089163A (en) 1989-01-30 1992-02-18 Lever Brothers Company, Division Of Conopco, Inc. Enzymatic liquid detergent composition
US5484777A (en) 1989-04-20 1996-01-16 Lange, Iii; Louis G. Pancreatic cholesterol esterase inhibitor
US5063210A (en) 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
US5674482A (en) 1989-08-14 1997-10-07 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Polymers with alkyl- or heteroalkyl -aryl backbone and pharmaceutical compositions incorporating same
ATE145672T1 (de) 1989-08-29 1996-12-15 Univ California Neue inhibitoren für hydrolytische enzyme und substrate und bestimmungsverfahren, selbige einschliessende verfahren und testsätze
US5308766A (en) 1989-08-29 1994-05-03 The Regents Of The University Of California Hydrolytic enzyme inhibitors/inactivators and methods for using same
US5376640A (en) * 1989-12-25 1994-12-27 Nisshin Flour Milling Co., Ltd. Lipolytic enzyme inhibitors
US5260310A (en) 1990-02-26 1993-11-09 Hoffmann-La Roche Inc. Oxetanone compounds and pharmaceutical compositions containing them
DK244090D0 (da) 1990-10-09 1990-10-09 Novo Nordisk As Kemiske forbindelser
US5137716A (en) 1990-11-15 1992-08-11 Weisenfeld Michael S Method of reducing weight in mammals
KR0179675B1 (ko) 1992-01-14 1999-03-20 나까토미 히로타카 콜레스테롤저하제
CA2063499C (fr) 1992-03-19 1996-06-18 Leon Edward St. Pierre Sels de phosphonium polymeriques ingerables permettant de faire baisser le taux de cholesterol sanguin
JP2667351B2 (ja) 1992-03-24 1997-10-27 麒麟麦酒株式会社 食餌脂質消化吸収阻害剤および飲食品
DK0563731T3 (da) 1992-03-28 1996-03-18 Hoechst Ag Lægemidler indeholdende polyhydromethylenderivater, fremgangsmåde til deres fremstilling og deres anvendelse
RU2066185C1 (ru) * 1993-01-11 1996-09-10 Институт пищевых веществ РАН Гиполипидемический энтеросорбент
US5607669A (en) 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5618530A (en) 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5703188A (en) 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5624963A (en) 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5569452A (en) 1993-08-31 1996-10-29 Tsrl, Inc. Pharmaceutical formulation having enhanced bile acid binding affinity
US5414068A (en) 1994-01-24 1995-05-09 Rohm And Haas Company Crosslinked anion exchange particles and method for producing the particles
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US5474993A (en) 1994-06-14 1995-12-12 Sterling Winthrop, Inc. Lactam inhibitors of cholesterol esterase
JPH0859458A (ja) 1994-08-25 1996-03-05 Zeria Pharmaceut Co Ltd インダン誘導体を含有する高脂血症治療剤
JP3532999B2 (ja) 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
US5993675A (en) * 1997-12-31 1999-11-30 Hagerthy; Albert P. Fuel-water separator for marine and diesel engines
AU740233B2 (en) * 1998-01-09 2001-11-01 Genzyme Corporation Fat-binding polymers
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
US6299868B1 (en) * 1999-07-14 2001-10-09 Geltex Pharmaceuticals, Inc. Fat-binding polymers
US5942500A (en) * 1998-04-27 1999-08-24 Perry; Stephen C. Dietary composition to reduce dietary fats

Also Published As

Publication number Publication date
EP1043982A2 (fr) 2000-10-18
IL137098A0 (en) 2001-06-14
PL193453B1 (pl) 2007-02-28
NO20003511D0 (no) 2000-07-07
PL344022A1 (en) 2001-09-24
IL137098A (en) 2006-07-05
HK1079706A1 (zh) 2006-04-13
NZ505296A (en) 2002-12-20
DE69928219D1 (de) 2005-12-15
ATE308979T1 (de) 2005-11-15
DK1043982T3 (da) 2006-02-13
US6875428B2 (en) 2005-04-05
EP1043982B1 (fr) 2005-11-09
US6572850B1 (en) 2003-06-03
CA2318416A1 (fr) 1999-07-15
US6267952B1 (en) 2001-07-31
US20030185789A1 (en) 2003-10-02
US6558657B1 (en) 2003-05-06
HUP0101128A3 (en) 2003-01-28
KR20010034012A (ko) 2001-04-25
RU2207861C2 (ru) 2003-07-10
WO1999034786A2 (fr) 1999-07-15
KR100620634B1 (ko) 2006-09-13
AU2105699A (en) 1999-07-26
US20050085535A1 (en) 2005-04-21
CN1287489A (zh) 2001-03-14
HUP0101128A2 (hu) 2002-01-28
CN1636574A (zh) 2005-07-13
BR9907233A (pt) 2000-10-17
ES2253872T3 (es) 2006-06-01
DE69928219T2 (de) 2006-07-27
WO1999034786A3 (fr) 2000-02-03
US6352692B1 (en) 2002-03-05
JP2002500182A (ja) 2002-01-08
AU747016B2 (en) 2002-05-09

Similar Documents

Publication Publication Date Title
NO20003511L (no) Lipase-inhiberende polymerer
ES2195993T3 (es) Metodo para inhibir la produccion de etileno en plantas.
DE69408993D1 (de) Verfahren zur Bestimmung von Mikroorganismen mittels mindestens zwei Chromogene
DE68925002D1 (de) Verfahren zur Herstellung von optisch-aktiven alpha-substituierten organischen Säuren und Mikroorganismen und Enzyme, die dafür verwendet werden.
BRPI0411874A (pt) potencial de staygreen controlado em plantas por gene simples obtido por engenharia genética
ATE329047T1 (de) Stimulierung der homologen rekombination in pflanzlichen organismen mittels rekombinations fördernder enzyme
ATE294815T1 (de) Methode zur regulation der ligninzusammensetzung in pflanzen
BR9510604A (pt) Aperfeiçoamento do rendimento de plantas
BR0003943A (pt) Sequências de nucleotìdeo que codificam para o gene thre e processo para a produção enzimática de l-treonina usando bactérias corineforma
BRPI0411182A (pt) método para aumentar a toleráncia de uma planta ao estresse abiótico, método para aumentar a biomassa de uma planta, construto de ácido nucléico, polipeptìdio isolado e célula de planta
HUP9901198A2 (hu) Eljárás L-aminosavak előállítására
CA2256758A1 (fr) Methode de production de l-serine par fermentation
WO1998002550A3 (fr) Production microbienne d'isoprene
IL112061A0 (en) Methods for the preparation of taxanes
BR9007975A (pt) Preparacao que apresenta atividade enzimatica processo para produzir a mesma,cepas isoladas de bacillus stearo thermophilus,e processo para o tratamento de polpa de madeira
EP1672061A3 (fr) Séquences nucléotidiques codant pour des enzymes ACC synthase
TW221804B (fr)
Suzuki et al. A cold-active esterase with a substrate preference for vinyl esters from a psychrotroph, Acinetobacter sp. strain no. 6: gene cloning, purification, and characterization
AU5942998A (en) Enzymic triglyceride conversion
JPH0561910B2 (fr)
DK0759981T3 (da) Fremgangsmåde til dyrkning af bakterier, der producerer proteiner, som udtrykkes på en temperaturreguleret måde
BR0005307A (pt) Processo para a produção fermentativa de l-lisina usando bactérias coryneform
ATE153067T1 (de) Molekulare klonierung und expression von genen, die für lipolytische enzyme kodieren
BR0317507A (pt) Método para a produção de um aminoácido
SE9201006D0 (sv) Delignifying preparation exhibiting alpha-l-arabino -furanosidase activity, production and application thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application